Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review

Detalhes bibliográficos
Autor(a) principal: Martins, Ana
Data de Publicação: 2022
Outros Autores: Gomes, Ana L., Vilas Boas, Inês, Marto, Joana, Ribeiro, Helena
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10451/58903
Resumo: © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
id RCAP_ea59ffee4a4b16ba1d11b8cb555a24f9
oai_identifier_str oai:repositorio.ul.pt:10451/58903
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely ReviewCannabis sativaCannabinoidsCBDTHCDermatological inflammatory diseases© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).The use of natural products in dermatology is increasingly being pursued due to sustainability and ecological issues, and as a possible way to improve the therapeutic outcome of chronic skin diseases, relieving the burden for both patients and healthcare systems. The legalization of cannabis by a growing number of countries has opened the way for researching the use of cannabinoids in therapeutic topical formulations. Cannabinoids are a diverse class of pharmacologically active compounds produced by Cannabis sativa (phytocannabinoids) and similar molecules (endocannabinoids, synthetic cannabinoids). Humans possess an endocannabinoid system involved in the regulation of several physiological processes, which includes naturally-produced endocannabinoids, and proteins involved in their transport, synthesis and degradation. The modulation of the endocannabinoid system is a promising therapeutic target for multiple diseases, including vascular, mental and neurodegenerative disorders. However, due to the complex nature of this system and its crosstalk with other biological systems, the development of novel target drugs is an ongoing challenging task. The discovery of a skin endocannabinoid system and its role in maintaining skin homeostasis, alongside the anti-inflammatory actions of cannabinoids, has raised interest in their use for the treatment of skin inflammatory diseases, which is the focus of this review. Oral treatments are only effective at high doses, having considerable adverse effects; thus, research into plant-based or synthetic cannabinoids that can be incorporated into high-quality, safe topical products for the treatment of inflammatory skin conditions is timely. Previous studies revealed that such products are usually well tolerated and showed promising results for example in the treatment of atopic dermatitis, psoriasis, and contact dermatitis. However, further controlled human clinical trials are needed to fully unravel the potential of these compounds, and the possible side effects associated with their topical use.This research was funded by FCT (Fundação para a Ciência e a Tecnologia) through iMed.ULisboa UID/DTP/04138/2020 and UIDB/04138/2020). Joana Marto is financed through FCT, I.P., under the Scientific Employment Stimulus—Institutional Call (CEECINST/00145/2018).MDPIRepositório da Universidade de LisboaMartins, AnaGomes, Ana L.Vilas Boas, InêsMarto, JoanaRibeiro, Helena2023-08-16T18:45:33Z2022-022022-12-17T15:47:31Z2022-02-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10451/58903engMartins AM, Gomes AL, Vilas Boas I, Marto J, Ribeiro HM. Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review. Pharmaceuticals [Internet]. 2022 Feb 9;15(2):210. Available from: http://dx.doi.org/10.3390/ph15020210https://www.mdpi.com/1424-8247/15/7/849cv-prod-279303710.3390/ph15020210info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-08T17:02:24Zoai:repositorio.ul.pt:10451/58903Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T22:06:05.984123Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review
title Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review
spellingShingle Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review
Martins, Ana
Cannabis sativa
Cannabinoids
CBD
THC
Dermatological inflammatory diseases
title_short Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review
title_full Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review
title_fullStr Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review
title_full_unstemmed Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review
title_sort Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review
author Martins, Ana
author_facet Martins, Ana
Gomes, Ana L.
Vilas Boas, Inês
Marto, Joana
Ribeiro, Helena
author_role author
author2 Gomes, Ana L.
Vilas Boas, Inês
Marto, Joana
Ribeiro, Helena
author2_role author
author
author
author
dc.contributor.none.fl_str_mv Repositório da Universidade de Lisboa
dc.contributor.author.fl_str_mv Martins, Ana
Gomes, Ana L.
Vilas Boas, Inês
Marto, Joana
Ribeiro, Helena
dc.subject.por.fl_str_mv Cannabis sativa
Cannabinoids
CBD
THC
Dermatological inflammatory diseases
topic Cannabis sativa
Cannabinoids
CBD
THC
Dermatological inflammatory diseases
description © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
publishDate 2022
dc.date.none.fl_str_mv 2022-02
2022-12-17T15:47:31Z
2022-02-01T00:00:00Z
2023-08-16T18:45:33Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10451/58903
url http://hdl.handle.net/10451/58903
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Martins AM, Gomes AL, Vilas Boas I, Marto J, Ribeiro HM. Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review. Pharmaceuticals [Internet]. 2022 Feb 9;15(2):210. Available from: http://dx.doi.org/10.3390/ph15020210
https://www.mdpi.com/1424-8247/15/7/849
cv-prod-2793037
10.3390/ph15020210
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799134613837185024